Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.29 +0.06 (+4.86%)
As of: Oct 1, 2026 · 3:59 PM EDT

Aldeyra Therapeutics (ALDX) Return on Equity [ROE] (2014 - 2026)

Updated

Aldeyra Therapeutics' Return on Equity [ROE] was -57.60% in Q2 2026, up 27.55 percentage points from -85.15% a year earlier and up 5.75 percentage points from the prior quarter.

Analysis

Aldeyra Therapeutics (ALDX) Return on Equity [ROE] (2014 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Aldeyra Therapeutics came in at -58.73%, down 0.19 percentage points from FY2024.

  • Return on Equity [ROE] shows a five-year change of +11.08 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Equity [ROE] was -58.54% in FY2024 (-30.82 pp), -27.73% in FY2023 (+7.05 pp), -34.77% in FY2022 (+8.79 pp) and -43.56% in FY2021 (+26.24 pp).
  • The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q3 2024.
  • Compared with a year earlier, Return on Equity [ROE] was higher in two of the last eight quarters, with an average year-over-year change of -18.43 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q3 2021 (a gain of 41.13 percentage points); the worst was Q1 2025 (a drop of 60.00 percentage points).
  • Per Business Quant data, ALDX's Return on Equity [ROE] in the three quarters before Q2 2026 was -63.35% (Q1 2026), -72.40% (Q4 2025) and -82.64% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Aldeyra Therapeutics 74.19 Mn 74.19 Mn - -57.60%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -57.60%
Mar 31, 2026 -63.35%
Dec 31, 2025 -72.40%
Sep 30, 2025 -82.64%
Jun 30, 2025 -85.15%
Mar 31, 2025 -85.73%
Dec 31, 2024 -71.56%
Sep 30, 2024 -48.85%
Jun 30, 2024 -35.77%
Mar 31, 2024 -25.74%
Dec 31, 2023 -30.92%
Sep 30, 2023 -36.14%
Jun 30, 2023 -38.98%
Mar 31, 2023 -42.22%
Dec 31, 2022 -39.61%
Sep 30, 2022 -38.59%
Jun 30, 2022 -36.26%
Mar 31, 2022 -31.92%
Dec 31, 2021 -27.16%
Sep 30, 2021 -23.52%
API Access

Aldeyra Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ALDX&period=max&api_key=YOUR_API_KEY